GeoVax Labs Inc (NASDAQ:GOVX) shares continue to rally Monday adding to gains of more than 225% over the past week. Here’s a look at what you need to know. What To Know: GeoVax, and several healthcare ...
Fintel on MSN
D Boral Capital downgrades GeoVax Labs (GOVX)
Fintel reports that on February 19, 2026, D. Boral Capital downgraded their outlook for GeoVax Labs (NasdaqCM:GOVX) from Buy to Hold. Analyst Price Forecast Suggests 16,961.15% Upside As of February 4 ...
After reaching an important support level, GeoVax Labs Inc. (GOVX) could be a good stock pick from a technical perspective. GOVX recently experienced a "golden cross" event, which saw its 50-day ...
$GOVX insiders have traded $GOVX stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...
GeoVax announces an offering of 1.7 million shares at a price of $5 per share. GeoVax says it expects approximately $8.5 million in gross proceeds from the offering. Get daily-updated rankings across ...
The economy of the United States has stabilized, the risks of a recession have been delayed, and inflation continues to cool down. On August 30, Reuters reported that the Federal Reserve received a ...
GeoVax Labs Inc.’s stock tumbled 20% early Tuesday, after the clinical-stage biotech said it’s entered an agreement with an institutional investor for the purchase and sale of 1.7 million shares ...
GOVX stock opened at $1.11 on Friday. GeoVax Labs has a one year low of $1.09 and a one year high of $11.18. The firm has a market cap of $10.47 million, a PE ratio of -0.20 and a beta of 3.06. The ...
Shares of GeoVax (NASDAQ:GOVX) shot up 50% in mid-afternoon trading Tuesday amid news that the US government plans to fund a Phase 2b study of the company's next-generation COVID-19 vaccine. GeoVax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results